# 8-K filed: Fulcrum Therapeutics, Inc.

> sec 8k · VERIFIED · 2026-08-17

Filed: 2026-08-17 AccNo: 0001193125-26-353278 Size: 15 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

- Company: Fulcrum Therapeutics, Inc.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1680581/000119312526353278/0001193125-26-353278-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.